EYE ON CHINA

2014 ◽  
Vol 18 (09) ◽  
pp. 19-24
Keyword(s):  
Strategic Alliance ◽  
Life Sciences ◽  
High Yield ◽  
State Institute ◽  
University Center ◽  
Research Institutes ◽  
Scientific Corporation ◽  
Peking University ◽  
Drug Eluting ◽  
Cook Medical

NEWS – Canbridge Life Sciences and EUSA Pharma form agreement to commercialize prescription medical device in China. NEWS – miacom diagnostics GmbH teams up with Fosun Diagnostics to bring diagnostic arrays to Chinese and Asian markets. NEWS – Medtronic and Lifetech Scientific Corporation expand strategic alliance to bring pacemakers to China. NEWS – Wearable device for the early detection of common diabetes-related neurological condition. NEWS – Herbalife plans expansion of manufacturing capabilities in China. NEWS – Cook Medical enrolls first patient in drug eluting peripheral stent clinical study in China. NEWS – Provectus Signs Memorandum of Understanding with Sinopharm-China State Institute of Pharmaceutical Industry, and Sinopharm A-THINK Pharmaceutical Co., Ltd. NEWS – Scientists develop new high yield allele to improve rice production. RESEARCH INSTITUTES – The Peking University Center of Bioinformatics.

EYE ON CHINA

2014 ◽  
Vol 18 (02) ◽  
pp. 21-29
Keyword(s):  
Joint Venture ◽  
Green Energy ◽  
Business Leaders ◽  
Antibody Treatment ◽  
Chinese Business ◽  
Scientific Corporation ◽  
Peking University ◽  
Business In China ◽  
New Research

Hepalink signs agreement to acquire Scientific Protein Laboratories. Yasheng Group joint venture with IBC International LLC to form Angel Star Nutrition LLC. Zynex signs distribution agreement for China market. Tao Li of China Green Agriculture, receives the honor of “Future Chinese Business Leaders”. Yingli Green Energy enters joint venture with Datong Coal Mine Group. Elekta wins public tender to deliver cancer care solutions to China. Stellar Biotechnologies Announces Collaboration with Amaran Biotechnology, Inc. TaiGen Biotechnology signed exclusive license agreement with R-Pharm for nemonoxacin (Taigexyn). Eddingpharm acquires global rights to oncology assets, including Telatinib, from ACT Biotech. BioLineRx and JHL Biotech to collaborate on Type 1 diabetes antibody treatment. Bayer and Peking University establish new research center for translational research and drug discovery in Beijing. Microport Scientific Corporation and Sorin Group sign joint venture agreement for cardiac rhythm management business in China. Epigenomics signs licensing and supply agreement with Kindstar for Epi proLung in China. Abcam to open office in Shanghai, China.

General Information & Statistics

2002 ◽  
Vol 06 (23) ◽  
pp. 881-890
Keyword(s):  
Life Sciences ◽  
Medical Engineering ◽  
General Information ◽  
Smoking Rate ◽  
Major Health ◽  
Oncology Research ◽  
Research Institutes ◽  
High Mercury ◽  
Engineering Conference ◽  
To Receive

Major Health Research Institutes to Receive Funding. Record Number of Hepatitis C Infections in Australia. Needle Schemes Prevents HIV and HCV Infections. Sino-French Life Sciences Center Established. Ten Percent of HK Students Have High Mercury Exposure. India Emerges as Biotech R&D Hub. Adult Smoking Rate at All-time Low. Japan’s Nobel Laureates Hope to Inspire Science Boom. NZ Lays out Biotechnology Strategy. IRRI Sets up Rice Knowledge Bank. Students to Learn Life Sciences through BioCamp. Singapore Sets Up Oncology Research Institute. Agrobiology Scientists Move into New Institution. Survey Shows Singapore Biomed Industry Highly Rated. Biological and Medical Engineering Conference in Singapore. Taiwan Shares Malaria Experience.

scholarly journals Meeting Review: Bioinformatics and Medicine – From Molecules to Humans, Virtual and Real

2002 ◽  
Vol 3 (3) ◽  
pp. 270-276
Author(s):  
Roslin Russell
Keyword(s):  
Protein Structure ◽  
Modeling And Simulation ◽  
High Throughput ◽  
Protein Interactions ◽  
Life Sciences ◽  
Systems Modeling ◽  
Protein Protein Interactions ◽  
Research Institutes ◽  
The Government ◽  
Structure Research

The Industrialization Workshop Series aims to promote and discuss integration, automation, simulation, quality, availability and standards in the high-throughput life sciences. The main issues addressed being the transformation of bioinformatics and bioinformaticsbased drug design into a robust discipline in industry, the government, research institutes and academia. The latest workshop emphasized the influence of the post-genomic era on medicine and healthcare with reference to advanced biological systems modeling and simulation, protein structure research, protein-protein interactions, metabolism and physiology. Speakers included Michael Ashburner, Kenneth Buetow, Francois Cambien, Cyrus Chothia, Jean Garnier, Francois Iris, Matthias Mann, Maya Natarajan, Peter Murray-Rust, Richard Mushlin, Barry Robson, David Rubin, Kosta Steliou, John Todd, Janet Thornton, Pim van der Eijk, Michael Vieth and Richard Ward.

Industry Watch

2010 ◽  
Vol 14 (02) ◽  
pp. 21-35
Keyword(s):  
Drug Delivery ◽  
Strategic Alliance ◽  
Research Collaboration ◽  
Life Sciences ◽  
Consumer Health ◽  
Start Up ◽  
Otsuka Pharmaceutical ◽  
Development Agreement ◽  
Screening Services ◽  
Cd4 Testing

Patrys to Work with CSL to Explore Antibody Drugs. Starpharma and Lilly Sign New Drug Delivery Collaboration for Human Pharmaceuticals. Sanofi, Minsheng in China Consumer Health Venture. Biocon Signs MoU with Malaysia's BiotechCorp. Biocon, Bayer Tie up to Fight Diabetes in India. Ranbaxy to Acquire Bangalore Based Biovel Life Sciences. DiscoveRx, Jubilant Biosys Announce Agreement for Screening Services. BD Biosciences Collaborates with ReaMetrix to Develop New, Affordable CD4 Testing Products to Help Fight HIV/AIDS in Developing Countries. Aegis Therapeutics and Dr. Reddy's Announce Strategic Alliance. Penwest Enters Into Research and Development Agreement with Otsuka Pharmaceutical. AstraZeneca and CrystalGenomics Form Research Collaboration to Develop Novel Anti-Infective Treatments. International and Local Recognition for Singaporean Biotech Start-up – Curiox Biosystems. Roche Establishes New Medical Research Hub in Singapore. Virbac Unveils First Regional R&D Center in Asia.

Company News

2001 ◽  
Vol 05 (14) ◽  
pp. 291-301
Keyword(s):  
Medical Devices ◽  
Strategic Alliance ◽  
State Of The Art ◽  
Life Sciences ◽  
Medical Products ◽  
First Order ◽  
Commercial Use ◽  
Sign Distribution ◽  
Wastewater Recycling ◽  
Set Up

Cell Robotics' Medical Devices Well Received in China. US National Nutritional Foods Association and China's Sanjiu Pharmaceutical Establish Historic Partnership. Novacor LVAS Approved for Commercial Use in Japan. NOMOS and Lynmed to Jointly Distribute Medical Products in China and HK. Eli Lilly to Buy Out Ranbaxy's Stake. US-based Dragon Expands Business in Hong Kong and China. Australia's Global Doctor and US MedAire Announce Strategic Alliance. Taiwan's Gene Born Biotech Corp Adopts Thermogenesis's BioArchive System. Cepheid and BioSynTech Sign Distribution Agreement To Enter Life Sciences Research Market in Southeast Asia. Harbin Pharmaceutical Completes China's Largest Antibiotic Wastewater Recycling Project. Eli Lilly to Set Up State-of-the-Art Systems Biology R&D Center in Singapore. Varian Receives First Order for World's Most Powerful NMR Spectrometer from Japan.

ACADEMIC ENTREPRENEURSHIP IN LIFE SCIENCES: THE CASE OF A MODERATE INNOVATOR COUNTRY

2016 ◽  
Vol 21 (01) ◽  
pp. 1650004 ◽  
Author(s):  
AURORA A. C. TEIXEIRA ◽  
JOÃO NOGUEIRA
Keyword(s):  
Empirical Evidence ◽  
Academic Entrepreneurship ◽  
Life Science ◽  
Life Sciences ◽  
Econometric Analysis ◽  
Business Community ◽  
Entrepreneurial Activity ◽  
Academic World ◽  
Research Institutes ◽  
Start Up

The commercialization of research done by universities and research institutes is seen as a key element of entrepreneurship, justifying a better understanding of the entrepreneurial process within those institutions. Despite efforts in recent decades, there remains a widespread ignorance about who are the individuals with a greater vocation for research and marketing of knowledge. Focusing on a relatively unexplored context — the field of life sciences in a moderate innovator country, Portugal — this study adds new empirical evidence to the precedents of academic entrepreneurship. The results, based on 247 responses, evidence that entrepreneurship (including patent production, consultancy work and creation of start-up companies) is still very incipient. The econometric analysis of the “Index of entrepreneurial activity,” shows that: (1) the phenomenon of academic entrepreneurship is within everyone’s reach, but embraced by very few; and (2) academic entrepreneurship feeds on the exchange of knowledge and resources among universities and research institutes and their socio-economic environment. Thus, to increase academic entrepreneurship in life science in Portugal, the mechanisms to facilitate the interactions between universities and the business community must be strengthened, promoting the development of business clusters with the integration of the academic world, which will enable the transformation of knowledge into market products and services.

Industry Watch

2008 ◽  
Vol 12 (10) ◽  
pp. 60-86 ◽  
Keyword(s):  
Stem Cell ◽  
Life Sciences ◽  
Embryonic Stem ◽  
Antibody Drug Conjugate ◽  
Cancer Mutation ◽  
Processing Facility ◽  
Peking University ◽  
Therapeutic Compounds ◽  
Cell Storage ◽  
Antibody Drug

HealthLinx and InSymbiosis to Co-develop Therapeutic Compounds for Lung Disease. New Indication for VivaGel®: Bacterial Vaginosis. Stem Cell Sciences Granted UK Patent for New Growth Medium to Revolutionize Growth of Authentic Embryonic Stem Cells. DxS Launches Cancer Mutation Kit for K-RAS in Australia. Baxter and Peking University Third Hospital Advance Treatment of Chronic Kidney Disease through Region's First Education and Research Academy. WuXi PharmaTech Expands Collaboration with AstraZeneca. Beike Biotech Opens Comprehensive Stem Cell Storage and Processing Facility in China. Novartis Signs Pact with Lonza. Actelion Links with GlaxoSmithKline for Almorexant Development. Piramal Healthcare Acquires Haemaccel Brands Group of PlasmaSelect AG, Germany. Sigma-Aldrich Announces Collaboration with Metahelix Life Sciences. Seattle Genetics Announces Antibody-Drug Conjugate Collaboration with Daiichi Sankyo. Alnylam and Kyowa Hakko Form Alliance for the Development and Commercialization of ALN-RSV01 in Asia. Cobrabio Announces Manufacturing Agreement with ViroMed for VM206RY. Apollo Acquisition Boosts NZ Biotech Symansis. Installation of Southeast Asia's First Liquid Nitrogen- and Cryogen-Free Freezer at Singapore's NUH-NUS Tissue Repository. STMicroelectronics and Debiotech Announce First Prototypes of Disposable Insulin Nanopump.

scholarly journals “Low Echoic Area” around stent after bare and drug-coated stenting or stent graft placement for superficial femoral artery disease

2021 ◽  
Vol 9 ◽  
pp. 2050313X2110145
Author(s):  
Yoshimitsu Soga ◽  
Kenji Ando
Keyword(s):  
Stent Graft ◽  
Femoral Artery ◽  
Superficial Femoral Artery ◽  
Drug Eluting Stent ◽  
Drug Eluting ◽  
Cook Medical ◽  
Artery Disease ◽  
Zilver Ptx ◽  
Cordis Corporation

Restenosis after stent implantation in femoropopliteal lesions is still big issue. However, restenosis has been reduced by the recent new drug-eluting stent “Eluvia” (Boston Scientific, Marlborough, MA, USA). However, it was reported that “low echoic area (LEA)” finding around stent by ultrasound that they called “aneurysmal degeneration,” but no blood flow was identified outside the stent was confirmed after Eluvia implantation. In this report, we describe the similar findings that were observed after other types of stents (S.M.A.R.T. bare-nitinol stent (Cordis Corporation, Hialeah, FL, USA), Zilver PTX drug-coated stent (Cook Medical, Bloomington, IN, USA), and Viabahn stent graft (W. L. Gore & Associates, Newark, Delaware, USA)) for superficial femoral artery disease. These findings did not change to “aneurysmal change” during the follow-up.

Sign in / Sign up

Export Citation Format

Share Document